Published in Infect Dis Obstet Gynecol on January 01, 1996
Evaluation of the anti-Listeria potentials of some plant-derived triterpenes. Ann Clin Microbiol Antimicrob (2014) 0.78
Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol (1993) 1.45
Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol (1994) 1.30
Placental transfer of ampicillin. Am J Obstet Gynecol (1966) 1.26
Pharmacokinetics of ampicillin during pregnancy. J Infect Dis (1977) 1.14
Cerebral toxicity of penicillins in relation to their hydrophobic character. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.94
Plasma levels of ampicillin in pregnant women following administration of ampicillin and pivampicillin. Am J Obstet Gynecol (1978) 0.83
The penicillins. Obstet Gynecol Clin North Am (1992) 0.83
Transplacental passage of azidocillin, ampicillin and penicillin G during early and late pregnancy. Scand J Infect Dis (1970) 0.83
Passage of penicillins from mother to foetus in humans. Int J Clin Pharmacol (1972) 0.82
Antibody responses in acute and chronic rubella. Proc Soc Exp Biol Med (1966) 1.66
Understanding the bacterial flora of the female genital tract. Clin Infect Dis (2001) 1.62
Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther (1978) 1.51
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
The correlation of maternal cytomegalovirus infection during varying stages in gestation with neonatal involvement. J Pediatr (1972) 1.32
Quantitative and qualitative effects of povidone-iodine liquid and gel on the aerobic and anaerobic flora of the female genital tract. Am J Obstet Gynecol (1980) 1.32
Isolated myocarditis with recovery of ECHO type 9 virus from the myocardium. N Engl J Med (1967) 1.28
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
Individualization of phenytoin dosage regimens. Clin Pharmacol Ther (1977) 1.17
Impact of diverging anaerobic technology on cul-de-sac isolates from patients with endometritis-salpingitis-peritonitis. Am J Obstet Gynecol (1982) 1.17
Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int (2006) 1.17
Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. Antimicrob Agents Chemother (1978) 1.15
Cul-de-sac isolates from patients with endometritis-salpingitis-peritonitis and gonococcal endocervicitis. Am J Obstet Gynecol (1976) 1.13
Influence of food on the presystemic metabolism of drugs. Pharmacol Ther (1988) 1.12
Haemophilus (Corynebacterium) vaginalis septicemia. Am J Obstet Gynecol (1974) 1.11
Free drug concentration monitoring in clinical practice. Rationale and current status. Clin Pharmacokinet (1987) 1.04
Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance. J Pharm Sci (1974) 1.02
Absorption kinetics of procainamide in humans. J Pharm Sci (1977) 1.02
Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination. Clin Pharmacol Ther (1981) 1.01
Coexistent congenital cytomegalovirus and toxoplasmosis in a stillborn. Am J Dis Child (1973) 0.99
Factors influencing serum protein binding of lidocaine in humans. Anesth Analg (1981) 0.99
Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther (1984) 0.95
Interstitial pancreatitis in the congenital rubella syndrome. J Pediatr (1972) 0.93
Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry. J Chromatogr (1976) 0.92
Blood as a potential vehicle for the cytomegaloviruses. Am J Obstet Gynecol (1976) 0.92
In vitro ability of the group B streptococci to inhibit gram-positive and gram-variable constituents of the bacterial flora of the female genital tract. Infect Dis Obstet Gynecol (1995) 0.92
Chronic infection of the central nervous system with rubella virus. Neurology (1966) 0.92
Potential use of C-reactive protein determinations in obstetrics and gynecology. Obstet Gynecol Surv (1989) 0.91
Kinetics of the oral antiarrhythmic lidocaine congener, tocainide. Clin Pharmacol Ther (1976) 0.91
Choice of antibiotics and length of therapy in the treatment of acute salpingitis. Am J Med (1985) 0.90
Polymicrobial bacteremia in obstetric patients. Obstet Gynecol (1976) 0.90
The lack of association between the appearance of complement fixing antibodies and the recovery of virus in a child with congenital rubella. Pediatrics (1967) 0.90
Clinical response of patients with gonococcal endocervicitis and endometritis-salpingitis-peritonitis to doxycycline. Am J Obstet Gynecol (1977) 0.90
Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women. J Reprod Med (2000) 0.90
Cesarean section and genital herpesvirus infection. Obstet Gynecol (1979) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
Serologic and immunologic evaluation of neonates following maternal influenza infection during the second and third trimesters of gestation. Am J Obstet Gynecol (1972) 0.89
Pulmonary disease and drug kinetics. Clin Pharmacokinet (1978) 0.88
Clinical staging of acute bacterial salpingitis and its therapeutic ramifications. Am J Obstet Gynecol (1982) 0.88
The problem of maternal syphilis after serologic surveillance during pregnancy. Am J Obstet Gynecol (1973) 0.86
Classification and pathogenesis of vulvovaginal candidiasis. Am J Obstet Gynecol (1985) 0.85
Rubella antibody titer. The significance of low-titered rubella antibodies. Obstet Gynecol (1978) 0.85
Is current therapy for maternal syphilis inadequate for established fetal infection? Am J Obstet Gynecol (1994) 0.85
Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine. Am J Cardiol (1983) 0.85
Maternal mumps infection during gestation: observations on the progeny. Am J Obstet Gynecol (1974) 0.85
Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs. J Pharm Sci (1975) 0.84
A word of caution concerning photodynamic inactivation therapy for Herpesvirus hominis infections. Obstet Gynecol (1975) 0.84
Congenital rubella syndrome: study of 22 infants. Myocardial damage and other new clinical aspects. Am J Dis Child (1965) 0.84
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
Interrelationships within the bacterial flora of the female genital tract. Infect Dis Obstet Gynecol (1997) 0.84
Neonatal Streptococcus pneumoniae septicemia and meningitis. A case report. J Reprod Med (1990) 0.83
The pharmacokinetics of meperidine in acute trauma patients. J Trauma (1986) 0.83
Ileocolitis associated with measles (rubeola). Am J Dis Child (1970) 0.83
Experimental rubella in pregnant rhesus monkeys. J Infect Dis (1966) 0.83
Complement-fixing antibodies to the AD-169 strain of cytomegalovirus in banked blood. Transfusion (1974) 0.83
Clinical pharmacokinetics of pethidine: 1982. Clin Pharmacokinet (1983) 0.83
Effect of smoking on binding of lidocaine to human serum proteins. J Pharm Sci (1980) 0.82
The isolation and identification of Mycoplasma from Macaca mulatta. Lab Anim Care (1970) 0.82
Tocainide conjugation in humans: novel biotransformation pathway for a primary amine. J Pharm Sci (1980) 0.82
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Viral placentitis in congenital cytomegalovirus infection. Am J Clin Pathol (1972) 0.81
Pragmatic factors influencing the detection of Neisseria gonorrhoeae. Obstet Gynecol (1982) 0.81
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity. J Pharm Sci (1986) 0.81
Nonlinear pharmacokinetics of indocyanine green in the rabbit and rat. J Pharmacokinet Biopharm (1980) 0.81
In vitro sensitivity of Candida (Torulopsis) glabrata to clotrimazole. Am J Reprod Immunol (1989) 0.81
Genital herpesvirus infection in pregnancy. Obstet Gynecol (1974) 0.81
Development of a bacteria-independent model of the multiple organ failure syndrome. Arch Surg (1989) 0.80
Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection. J Chromatogr (1984) 0.80
Congenital cytomegalovirus infection. Am J Obstet Gynecol (1969) 0.80
Placental lesions in congenital giant pigmented nevi. Am J Clin Pathol (1974) 0.80
Visceral involvement by herpes simplex virus in eczema herpeticum. Am J Dis Child (1968) 0.80
Perinatal septicemia due to the Bacteroidaceae. Obstet Gynecol (1988) 0.79
Superfetation. Obstet Gynecol (1970) 0.79
Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase. Clin Pharmacol Ther (1980) 0.79
Mechanisms of nonlinear disposition kinetics of sulfamethazine. Clin Pharmacol Ther (1979) 0.79
Applicability of capillary gas liquid chromatography to the measurement of free fraction of disopyramide in human plasma. Res Commun Chem Pathol Pharmacol (1985) 0.79
Congenital herpes simplex type II infection. Am J Obstet Gynecol (1985) 0.79
Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP). Br J Clin Pharmacol (1989) 0.79
Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol (1993) 0.79
Spontaneous bacterial peritonitis associated with an intrauterine device. J Clin Gastroenterol (1986) 0.79
Penicillinase-producing Neisseria gonorrhoeae arrives in Nebraska. Nebr Med J (1990) 0.79
Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure. J Am Coll Cardiol (1983) 0.78
Dose-dependent pharmacokinetic behavior of lidocaine in the conscious dog. Res Commun Chem Pathol Pharmacol (1978) 0.78
Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA (1972) 0.78
Immunoglobulin G levels and the titers of specific antiviral antibodies in amniotic fluid. Am J Obstet Gynecol (1970) 0.78
Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease. Clin Infect Dis (2000) 0.78
The isolation and identification of Mycoplasma from Cercopithecus aethiops. Lab Anim Care (1970) 0.77
Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther (1985) 0.77
Perinatal bacteremia due to group F streptococci. Am J Perinatol (1992) 0.77
Herpes simplex infection associated with short-term use of a fetal scalp electrode. A case report. J Reprod Med (1992) 0.77
Endogenous accumulation products and serum protein binding in uremia. J Lab Clin Med (1981) 0.77
Successful treatment of maternal septicemia due to Listeria monocytogenes at 26 weeks' gestation. Obstet Gynecol (1985) 0.77
Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents. Cancer Res (1984) 0.77
How rare is congenital herpes simplex? A literature review. J Reprod Med (1989) 0.77
Infectious morbidity associated with pelvic exenteration. Gynecol Oncol (1980) 0.77
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotyping. Ther Drug Monit (1999) 0.77
Group A streptococcus as a cause of endometritis/salpingitis/peritonitis in a nongravid female. Obstet Gynecol (1977) 0.76
Significance of polymicrobial bacterial superinfection in the therapy of gonococcal endometritis-salpingitis-peritonitis. Obstet Gynecol (1980) 0.76
Neonatal considerations in the management of premature rupture of the fetal membranes. Obstet Gynecol Surv (1986) 0.76